Filing Details
- Accession Number:
- 0001127602-13-020617
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-18 10:47:27
- Reporting Period:
- 2013-06-14
- Filing Date:
- 2013-06-18
- Accepted Time:
- 2013-06-18 10:47:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1267878 | W Todd Kingma | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Executive Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-06-14 | 1,250 | $35.85 | 18,315 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-06-14 | 1,250 | $118.00 | 17,065 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option Right to Buy | Disposition | 2013-06-14 | 1,250 | $0.00 | 1,250 | $35.85 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,605 | 2018-08-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 961 | Indirect | By Trust |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on December 7, 2012. This 10b5-1 sales plan will expire on the close of business December 31, 2013.
- By Trust, of which the reporting person is the Trustee.
- Exercisable in 3 equal annual installments beginning 8/25/09.